CompletedNot Applicable

Effects of Whole-body Vibration Therapy on Type 2 Diabetic Patients with and Without Polyneuropathy

Turkey (Türkiye)60 participantsStarted 2024-04-01

Plain-language summary

The aim of this study is to show how whole body vibration training practiced for 12 weeks affects the levels of inflammatory biomarkers such as C reactive protein (CRP) and, interleukin-6 (IL-6), in Type 2 diabetic patients (T2DM) with and without peripheral neuropathy.

Who can participate

Age range30 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Participants must stand and walk o without using an assistive device.
✓. Participants must have a weight of less than 120 kg.

Exclusion criteria

✕. T2DM patients with advanced cardiovascular, renal, hepatic disease
✕. T2DM patients with diabetic retinopathy or nephropathy
✕. T2DM patients with untreated hypertension, rhythm disorders, and those who have undergone bypass surgery
✕. T2DM patients with ischemic changes in the resting ECG
✕. T2DM patients with untreated hypoglycemia or orthostatic hypotension
✕. T2DM patients who are unable to walk independently, or use of canes, crutches or wheelchairs
✕. T2DM patients who have open ulcers or wounds on load-bearing surfaces
✕. T2DM patients with inflammatory rheumatic diseases such as rheumatoid arthritis

What they're measuring

6 min walk test

Timeframe: 12 weeks

Trial details

NCT IDNCT06033508

SponsorPamukkale University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-11-01

View on ClinicalTrials.gov More Type 2 Diabetes trials